Empowered Funds’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Buy |
37,972
+26,596
| +234% | +$2.08M | 0.03% | 641 |
|
|
2025
Q1 | $825K | Sell |
11,376
-14,157
| -55% | -$1.03M | 0.01% | 1061 |
|
|
2024
Q4 | $1.89M | Buy |
25,533
+1,501
| +6% | +$111K | 0.03% | 757 |
|
|
2024
Q3 | $1.59M | Buy |
24,032
+2,324
| +11% | +$153K | 0.02% | 751 |
|
|
2024
Q2 | $2.01M | Buy |
21,708
+1,585
| +8% | +$146K | 0.03% | 610 |
|
|
2024
Q1 | $1.92M | Buy |
20,123
+12,112
| +151% | +$1.16M | 0.03% | 639 |
|
|
2023
Q4 | $611K | Buy |
8,011
+2,813
| +54% | +$214K | 0.02% | 945 |
|
|
2023
Q3 | $360K | Buy |
5,198
+963
| +23% | +$66.7K | 0.01% | 1017 |
|
|
2023
Q2 | $399K | Buy |
4,235
+1,570
| +59% | +$148K | 0.01% | 886 |
|
|
2023
Q1 | $220K | Buy |
+2,665
| New | +$220K | 0.01% | 490 |
|